Bellerophon Therapeutics Inc

NASDAQ:BLPH 11:10:31 AM EDT

0.92

-0.12 (-11.32%)

Earnings Announcements

Bellerophon Provides Clinical Program Update And Reports First Quarter 2022 Financial Results

Published: 05/11/2022 12:38 GMT

Bellerophon Therapeutics Inc (BLPH) - Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.59.

Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.